Pro-Dex Inc (NASDAQ:PDEX)’s share price passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.00 and traded as high as $13.75. Pro-Dex shares last traded at $13.75, with a volume of 5,862 shares.

Separately, Ascendiant Capital Markets set a $2,000.00 target price on Booking and gave the stock a “buy” rating in a report on Tuesday, May 14th.

The company has a market cap of $54.29 million, a PE ratio of 16.59 and a beta of 1.43. The company has a debt-to-equity ratio of 0.23, a quick ratio of 4.60 and a current ratio of 5.88. The firm has a fifty day moving average of $12.37.

Pro-Dex (NASDAQ:PDEX) last announced its earnings results on Thursday, May 9th. The medical instruments supplier reported $0.17 EPS for the quarter. The firm had revenue of $6.85 million during the quarter. Pro-Dex had a return on equity of 19.69% and a net margin of 12.98%.

In other Pro-Dex news, CEO Kirk Richard Lee Van, Jr. purchased 3,500 shares of the firm’s stock in a transaction that occurred on Tuesday, May 14th. The stock was purchased at an average cost of $13.25 per share, with a total value of $46,375.00. Following the purchase, the chief executive officer now owns 24,897 shares of the company’s stock, valued at $329,885.25. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Raymond E. Cabillot sold 8,977 shares of the firm’s stock in a transaction that occurred on Monday, April 29th. The stock was sold at an average price of $17.66, for a total value of $158,533.82. The disclosure for this sale can be found here. In the last quarter, insiders sold 48,739 shares of company stock valued at $821,291. Company insiders own 41.70% of the company’s stock.

Hedge funds have recently modified their holdings of the stock. BlackRock Inc. lifted its stake in shares of Pro-Dex by 49.2% during the 4th quarter. BlackRock Inc. now owns 12,369 shares of the medical instruments supplier’s stock worth $150,000 after acquiring an additional 4,078 shares during the last quarter. Dimensional Fund Advisors LP bought a new stake in shares of Pro-Dex during the 4th quarter worth approximately $183,000. O Shaughnessy Asset Management LLC bought a new stake in shares of Pro-Dex during the 1st quarter worth approximately $242,000. Deutsche Bank AG lifted its stake in shares of Pro-Dex by 146.7% during the 4th quarter. Deutsche Bank AG now owns 42,606 shares of the medical instruments supplier’s stock worth $514,000 after acquiring an additional 25,333 shares during the last quarter. Finally, Alambic Investment Management L.P. lifted its stake in shares of Pro-Dex by 6.2% during the 1st quarter. Alambic Investment Management L.P. now owns 73,583 shares of the medical instruments supplier’s stock worth $1,065,000 after acquiring an additional 4,291 shares during the last quarter. 12.96% of the stock is owned by hedge funds and other institutional investors.

About Pro-Dex (NASDAQ:PDEX)

Pro-Dex, Inc, together with its subsidiaries, designs, develops, and manufactures powered surgical instruments, dental instruments, and rotary air motors worldwide. It also manufactures plastic injection molds for various industries; and shavers and machined parts. In addition, it provides engineering, and quality and regulatory consulting services.

Further Reading: What is a Special Dividend?

Receive News & Ratings for Pro-Dex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro-Dex and related companies with MarketBeat.com's FREE daily email newsletter.